Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Immunology
Published in: BMC Immunology 1/2013

Open Access 01-12-2013 | Research article

Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation

Authors: Halonna Kelly, Rajakumar Mandraju, Jordana GA Coelho-dos-Reis, Moriya Tsuji

Published in: BMC Immunology | Issue 1/2013

Login to get access

Abstract

Background

It has been shown that human immunodeficiency virus (HIV)-1 infection induces the production of endogenous lipids required for effective viral production, and the cluster of differentiation (CD)1 molecule CD1d is downregulated by HIV-1 infection. However, the role of endogenous lipid presentation and the implications of CD1 downregulation by HIV-1 infection have not yet been characterized.

Results

In this study, we observed downregulation of both CD1c and CD1d expression through a Vpu-dependent and Nef-independent mechanism, and the concomitant HIV-1-induced production of host cholesterol decreased the extent of CD1c and CD1d modulation. While the modest downregulation of CD1c by HIV-1 infection decreased the ability of CD1c-restricted T cells to respond and secrete interferon-γ, the cholesterol upregulation in the same cells by HIV-1 infection appears to limit the downregulation of CD1c.

Conclusions

The two conflicting HIV-1-mediated changes in CD1c expression appear to minimize the modulation of CD1c expression, thus leading the host to maintain a CD1c-restricted T-cell response against HIV-1.
Appendix
Available only for authorised users
Literature
1.
Brigl M, Brenner MB: CD1: antigen presentation and T cell function. Annu Rev Immuno. 2004, 22: 817-890. 10.1146/annurev.immunol.22.012703.104608.CrossRef
2.
Moody DB, Zajonc DM, Wilson IA: Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol. 2005, 5 (5): 387-399. 10.1038/nri1605.CrossRefPubMed
3.
Tsuji M: Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell Mol Life Sci. 2006, 63 (16): 1889-1898. 10.1007/s00018-006-6073-z.CrossRefPubMed
4.
Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB: Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol. 2003, 4 (12): 1230-1237. 10.1038/ni1002.CrossRefPubMed
5.
De Libero G, Moran AP, Gober HJ, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, et al: Bacterial infections promote T cell recognition of self-glycolipids. Immunity. 2005, 22 (6): 763-772. 10.1016/j.immuni.2005.04.013.CrossRefPubMed
6.
Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM: Murine CD1d-restricted T cell recognition of cellular lipids. Immunity. 2000, 12 (2): 211-221. 10.1016/S1074-7613(00)80174-0.CrossRefPubMed
7.
Vincent MS, Xiong X, Grant EP, Peng W, Brenner MB: CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. J Immunol. 2005, 175 (10): 6344-6351.CrossRefPubMed
8.
Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA: Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989, 341 (6241): 447-450. 10.1038/341447a0.CrossRefPubMed
9.
Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR: CD1 recognition by mouse NK1+ T lymphocytes. Science. 1995, 268 (5212): 863-865. 10.1126/science.7538697.CrossRefPubMed
10.
Exley M, Garcia J, Balk SP, Porcelli S: Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med. 1997, 186 (1): 109-120. 10.1084/jem.186.1.109.PubMedCentralCrossRefPubMed
11.
Kawashima T, Norose Y, Watanabe Y, Enomoto Y, Narazaki H, Watari E, Tanaka S, Takahashi H, Yano I, Brenner MB, Sugita M: Cutting edge: major CD8 T cell response to live bacillus Calmette-Guerin is mediated by CD1 molecules. J Immunol. 2003, 170 (11): 5345-5348.CrossRefPubMed
12.
Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS: CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med. 2002, 8 (6): 588-593. 10.1038/nm0602-588.CrossRefPubMed
13.
Porcelli S, Morita CT, Brenner MB: CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature. 1992, 360 (6404): 593-597. 10.1038/360593a0.CrossRefPubMed
14.
Rosat JP, Grant EP, Beckman EM, Dascher CC, Sieling PA, Frederique D, Modlin RL, Porcelli SA, Furlong ST, Brenner MB: CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol. 1999, 162 (1): 366-371.PubMed
15.
Sieling PA, Ochoa MT, Jullien D, Leslie DS, Sabet S, Rosat JP, Burdick AE, Rea TH, Brenner MB, Porcelli SA, Modlin RL: Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol. 2000, 164 (9): 4790-4796.CrossRefPubMed
16.
Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G: Presentation of the same glycolipid by different CD1 molecules. J Exp Med. 2002, 195 (8): 1013-1021. 10.1084/jem.20011963.PubMedCentralCrossRefPubMed
17.
Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB: CD1-dependent dendritic cell instruction. Nat Immunol. 2002, 3 (12): 1163-1168. 10.1038/ni851.CrossRefPubMed
18.
Leslie DS, Vincent MS, Spada FM, Das H, Sugita M, Morita CT, Brenner MB: CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med. 2002, 196 (12): 1575-1584. 10.1084/jem.20021515.PubMedCentralCrossRefPubMed
19.
Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A: Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol. 1999, 163 (9): 4647-4650.PubMed
20.
21.
Yuan W, Dasgupta A, Cresswell P: Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat Immunol. 2006, 7 (8): 835-842. 10.1038/ni1364.CrossRefPubMed
22.
Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG: Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol. 2003, 170 (3): 1430-1434.CrossRefPubMed
23.
Chen N, McCarthy C, Drakesmith H, Li D, Cerundolo V, McMichael AJ, Screaton GR, Xu XN: HIV-1 down-regulates the expression of CD1d via Nef. Eur J Immunol. 2006, 36 (2): 278-286. 10.1002/eji.200535487.CrossRefPubMed
24.
Cho S, Knox KS, Kohli LM, He JJ, Exley MA, Wilson SB, Brutkiewicz RR: Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. Virology. 2005, 337 (2): 242-252. 10.1016/j.virol.2005.04.020.CrossRefPubMed
25.
Hage CA, Kohli LL, Cho S, Brutkiewicz RR, Twigg HL, Knox KS: Human immunodeficiency virus gp120 downregulates CD1d cell surface expression. Immunol Lett. 2005, 98 (1): 131-135. 10.1016/j.imlet.2004.10.025.CrossRefPubMed
26.
Leonard JA, Filzen T, Carter CC, Schaefer M, Collins KL: HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements. J Virol. 2011, 85 (14): 6867-6881. 10.1128/JVI.00229-11.PubMedCentralCrossRefPubMed
27.
Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK: Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood. 2010, 116 (11): 1876-1884. 10.1182/blood-2009-09-243667.PubMedCentralCrossRefPubMed
28.
Ono A, Freed EO: Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A. 2001, 98 (24): 13925-13930. 10.1073/pnas.241320298.PubMedCentralCrossRefPubMed
29.
van 't Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F: Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol. 2005, 79 (15): 10053-10058. 10.1128/JVI.79.15.10053-10058.2005.PubMedCentralCrossRefPubMed
30.
Zheng YH, Plemenitas A, Fielding CJ, Peterlin BM: Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci U S A. 2003, 100 (14): 8460-8465. 10.1073/pnas.1437453100.PubMedCentralCrossRefPubMed
31.
Nilsson A: Increased cholesterol-ester formation during forced cholesterol synthesis in rat hepatocytes. Eur J Biochem. 1975, 51 (2): 337-342. 10.1111/j.1432-1033.1975.tb03933.x.CrossRefPubMed
32.
Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D: Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006, 4 (11): e365-10.1371/journal.pbio.0040365.PubMedCentralCrossRefPubMed
Metadata
Title
Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation
Authors
Halonna Kelly
Rajakumar Mandraju
Jordana GA Coelho-dos-Reis
Moriya Tsuji
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2013
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-14-4

Other articles of this Issue 1/2013

BMC Immunology 1/2013 Go to the issue

Research article

Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models

Research article

An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells

Research article

Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation

Research article

Flow cytometric analysis of the CD4+ TCR Vβ repertoire in the peripheral blood of children with type 1 diabetes mellitus, systemic lupus erythematosus and age-matched healthy controls

Research article

Anti-tumor necrosis factor VNAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shock

Research article

Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits